(NYSE: LLY) Eli Lilly & Co's forecast annual revenue growth rate of 13.33% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.52%.
Eli Lilly & Co's revenue in 2026 is $79,665,800,000.On average, 33 Wall Street analysts forecast LLY's revenue for 2026 to be $84,189,327,751,210, with the lowest LLY revenue forecast at $79,834,609,968,520, and the highest LLY revenue forecast at $91,419,891,367,475. On average, 33 Wall Street analysts forecast LLY's revenue for 2027 to be $97,250,657,028,085, with the lowest LLY revenue forecast at $85,425,329,577,555, and the highest LLY revenue forecast at $108,817,111,285,740.
In 2028, LLY is forecast to generate $108,861,355,067,795 in revenue, with the lowest revenue forecast at $94,249,610,704,865 and the highest revenue forecast at $127,182,987,623,890.